IRIS
PATRONO, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.052
AS - Asia 2.327
EU - Europa 2.124
SA - Sud America 180
Continente sconosciuto - Info sul continente non disponibili 167
AF - Africa 37
OC - Oceania 2
Totale 8.889
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.911
SG - Singapore 885
CN - Cina 655
UA - Ucraina 372
IE - Irlanda 312
TR - Turchia 301
SE - Svezia 259
RU - Federazione Russa 251
GB - Regno Unito 237
DE - Germania 180
IT - Italia 177
VN - Vietnam 176
FR - Francia 169
BR - Brasile 140
IN - India 111
FI - Finlandia 91
BD - Bangladesh 61
CA - Canada 47
HK - Hong Kong 30
MX - Messico 27
AR - Argentina 17
IL - Israele 17
IQ - Iraq 16
ES - Italia 15
PL - Polonia 15
ZA - Sudafrica 14
JM - Giamaica 11
NL - Olanda 11
CR - Costa Rica 10
ID - Indonesia 10
JP - Giappone 10
GP - Guadalupe 8
SV - El Salvador 8
BE - Belgio 7
SA - Arabia Saudita 7
KR - Corea 6
PH - Filippine 6
SC - Seychelles 6
TT - Trinidad e Tobago 6
AT - Austria 5
CO - Colombia 5
CZ - Repubblica Ceca 5
EG - Egitto 5
EU - Europa 5
HN - Honduras 5
NI - Nicaragua 5
UY - Uruguay 5
VE - Venezuela 5
CW - ???statistics.table.value.countryCode.CW??? 4
DZ - Algeria 4
IR - Iran 4
LT - Lituania 4
PK - Pakistan 4
TW - Taiwan 4
BB - Barbados 3
BM - Bermuda 3
CL - Cile 3
EC - Ecuador 3
EE - Estonia 3
GT - Guatemala 3
JO - Giordania 3
MA - Marocco 3
MY - Malesia 3
RO - Romania 3
AU - Australia 2
AZ - Azerbaigian 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MD - Moldavia 2
OM - Oman 2
QA - Qatar 2
AE - Emirati Arabi Uniti 1
AI - Anguilla 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
GD - Grenada 1
GE - Georgia 1
KH - Cambogia 1
LB - Libano 1
LC - Santa Lucia 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
RS - Serbia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 8.731
Salva come PNG Salva come JPEG
Città #
Singapore 665
San Jose 447
Jacksonville 414
Chandler 365
Dublin 310
Ashburn 226
Beijing 190
Southend 172
Izmir 147
Princeton 143
Dallas 137
Council Bluffs 121
Wilmington 107
Nanjing 102
Santa Clara 99
Los Angeles 98
Dearborn 75
Cambridge 67
Buffalo 57
Ho Chi Minh City 53
New York 52
Munich 44
The Dalles 42
Ann Arbor 41
Tongling 39
Hanoi 38
Washington 38
Nanchang 36
Woodbridge 36
Moscow 35
Altamura 29
Hong Kong 28
Phoenix 25
Shenyang 23
Kunming 21
Helsinki 19
Houston 19
Boardman 18
Jiaxing 18
Grevenbroich 17
Hebei 17
Chicago 16
Orem 16
São Paulo 16
Atlanta 15
Brooklyn 15
Changsha 15
Augusta 14
Hefei 13
Norwalk 13
Boston 12
Chieti 12
Columbus 12
Milan 12
Montreal 12
Redondo Beach 12
Rome 12
Tianjin 12
Johannesburg 11
San Francisco 11
Warsaw 11
Haiphong 10
Hangzhou 10
San Mateo 10
Silver Spring 10
Tokyo 10
Da Nang 9
Falls Church 9
Frankfurt am Main 9
Murcia 9
Newark 9
North Bergen 9
Orange 9
San José 9
Baghdad 8
Chennai 8
Kingston 8
Lanzhou 8
Seattle 8
Toronto 8
Brussels 7
Jinan 7
Leawood 7
Mexico City 7
Naples 7
San Salvador 7
Shanghai 7
Denver 6
Kimball 6
Lucca 6
Miami 6
Milwaukee 6
Philadelphia 6
Poplar 6
Queens 6
Querétaro 6
Stockholm 6
Amsterdam 5
Belo Horizonte 5
League City 5
Totale 5.186
Salva come PNG Salva come JPEG
Nome #
Low-dose aspirin acetylates cyclooxygenase-1 in human colorectal mucosa: implications for the chemoprevention of colorectal cancer. 212
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 206
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 189
Platelet-specific deletion of cyclooxygenase-1 ameliorates dextran sulfate sodium-induced colitis in mice. 187
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 180
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 172
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 169
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 155
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 152
Thromboxane biosynthesis and pulmonary function in cystic fibrosis 151
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 151
Aspirin, platelet inhibition and cancer prevention. 146
Insulin resistance as a determinant of platelet activation in obese women. 144
Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: A mechanistic and clinical perspective 144
Aspirin after acute myocardial infarction: a systematic approach to compare the hemostatic effects of three different doses. 141
Determinants of platelet activation in human essential hypertension. 140
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 138
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 137
Immunological characterization uf urinary 8-epi-prostaglandin f2alfa excretion in man 135
Cyclooxygenase-2 expression and inhibition in atherothrombosis. 134
Increased thromboxane biosynthesis in essential thrombocythemia 133
Role of Platelet Activation in Dementia 133
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. 132
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 132
Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. 131
Mechanisms, consequences, and prevention of coronary graft failure 131
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 130
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 128
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 127
Determinants of platelet activation in Alzheimer's disease 127
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 126
Increased thromboxane production by monocyte prostaglandin endoperoxide synthase-2 in patients with acute myocardial infarction (pubbl. su Suppl. Circulation) 124
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial 122
In vivo formation of 8-epi-prostaglandin F2alpha in increased in hypercholesterolemia. An aspirin-insensitive amplification mechanism of platelet activation (pubbl su Suppl Thromb Haemostas) 121
Effects of nabumetone on prostanoid biosynthesis in humans. 121
Cyclooxygenase-2 polymorphism: putting a brake on the inflammatory response to vascular injury? 121
Drugs, prostaglandins, and renal function. 121
Differential Expression and Regulation of Cyclooxygenase Isozymes in Thymic Stromal Cells. 121
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 120
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 120
Platelet activation in obese women: role of inflammation and oxidant stress. 119
Insulin resistance as a determinant of platelet activation in obese women 119
Antiplatelet agents in the prevention of diabetic vascular complications 117
Determinants of Thromboxane-Dependent Platelet Activation in Heart Failure. 116
Determinants of Platelet Activation in Heart Failure. 114
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 113
Nutraceuticals in diabetes and metabolic syndrome. 111
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 111
In vivo formation of 8-EPI-prostaglandin F2 alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 111
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 108
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 107
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 107
Cyclooxygenase-2 expression and inhibition in human monocytes 106
Determinants of Platelet Activation in Heart Failure. 103
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 103
Soluble CD40L as an indicator of platelet Activation in Heart Failure 101
In vivo formation of 8-iso-prostaglandin F2a and aspirin-insensitive thromboxane biosynthesis in unstable angina 100
Insulin resistance as a determinant of platelet activation in obese women 99
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 98
Short term Vitamin E treatment normalizes LDL oxidative susceptibility in diabetic subjects. 97
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 97
Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothiophenyl)-1-indanone (L-745,337), on the cyclo-oxygenase activity of human blood prosta-glandin endoperoxide synthases 96
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 96
In vivo formation of 8-isoprostaglandin F-2 alpha and platelet activation in diabetes mellitus. Effects of improved metabolic control and vitamin E supplementation 95
Effects of successful weight loss or pioglitazone on thromboxane-dependent platelet activation in obese women 89
Thromboxane biosynthesis in cardiovascular diseases 87
Increased thromboxane biosynthesis in type IIa hypercholesterolemia 85
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 85
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors 84
Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man 75
In vivo platelet activation in diabetes mellitus 63
Off-pump coronary artery bypass grafting: 30 years of debate 61
Platelet activation, aspirin, and cancer: From basic science to clinical trials 12
Totale 8.889
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.806
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022217 0 0 0 0 26 5 7 18 25 9 41 86
2022/2023989 81 129 80 98 89 211 57 62 125 13 19 25
2023/2024417 32 10 31 13 30 113 126 18 2 3 5 34
2024/20251.184 95 283 202 16 9 41 12 29 79 41 128 249
2025/20262.530 236 114 222 261 288 155 468 100 286 201 130 69
2026/2027895 88 155 162 360 130 0 0 0 0 0 0 0
Totale 8.889